Author Question: When reassessing a patient after administering epinephrine, be aware that when given intramuscularly ... (Read 59 times)

mspears3

  • Hero Member
  • *****
  • Posts: 586
When reassessing a patient after administering epinephrine, be aware that when given intramuscularly the duration of this medication is about:
 
  A) 510 minutes.
  B) 1020 minutes.
  C) 2030 minutes.
  D) an hour.

Question 2

Which of the following is a generic name?
 
  A) Demerol Hydrochloride
  B) Ethyl 1-methyl-4-phenyl-isonipecotate hydrochloride
  C) Meperidine hydrochloride
  D) Meperidine hydrochloride, USP



ciecieme

  • Sr. Member
  • ****
  • Posts: 331
Answer to Question 1

B

Answer to Question 2

C



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

The use of salicylates dates back 2,500 years to Hippocrates’s recommendation of willow bark (from which a salicylate is derived) as an aid to the pains of childbirth. However, overdosage of salicylates can harm body fluids, electrolytes, the CNS, the GI tract, the ears, the lungs, the blood, the liver, and the kidneys and cause coma or death.

Did you know?

Coca-Cola originally used coca leaves and caffeine from the African kola nut. It was advertised as a therapeutic agent and "pickerupper." Eventually, its formulation was changed, and the coca leaves were removed because of the effects of regulation on cocaine-related products.

Did you know?

Egg cells are about the size of a grain of sand. They are formed inside of a female's ovaries before she is even born.

Did you know?

Patients should never assume they are being given the appropriate drugs. They should make sure they know which drugs are being prescribed, and always double-check that the drugs received match the prescription.

Did you know?

Over time, chronic hepatitis B virus and hepatitis C virus infections can progress to advanced liver disease, liver failure, and hepatocellular carcinoma. Unlike other forms, more than 80% of hepatitis C infections become chronic and lead to liver disease. When combined with hepatitis B, hepatitis C now accounts for 75% percent of all cases of liver disease around the world. Liver failure caused by hepatitis C is now leading cause of liver transplants in the United States.

For a complete list of videos, visit our video library